EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper
Denmark to ditch AstraZeneca shot, delaying vaccine rollout: media
Yeah, they ditch AZ and buy Vaxzevria!
-----------
Everything is fine!
---------
https://www.reuters.com/article/us-...er-shots-in-second-quarter-idUSKBN2C11I4?il=0
Do they charge ?I was at Walmart yesterday and even they have vaccination by appointment now
From what I've heard, pharmacies do charge. However the city has been running a big vaccination clinic since March that is entirely free. That's where I went. It is quite the assembly line operation and surprisingly fast. I had no idea it would be at little pharmacies so quickly.Do they charge ?
When I got my az jab filling in the paperwork took many times longer than the actual vaccination
Actually I got the Pfizer vaccine in the CVS pharmacy at no cost. I don't believe they are allowed to charge since they do not purchase the vaccine. The vaccines in the US are free and should be for quite a while.From what I've heard, pharmacies do charge. However the city has been running a big vaccination clinic since March that is entirely free. That's where I went. It is quite the assembly line operation and surprisingly fast. I had no idea it would be at little pharmacies so quickly.
Conclusion Vaccination with a single dose of Oxford-AstraZeneca or Pfizer-BioNTech vaccines, or two doses of Pfizer-BioNTech, significantly reduced new SARS-CoV-2 infections in this large community surveillance study. Greater reductions in symptomatic infections and/or infections with a higher viral burden are reflected in reduced rates of hospitalisations/deaths, but highlight the potential for limited ongoing transmission from asymptomatic infections in vaccinated individuals.
From 1st December 2020 to 03rd April 2021, 373,402 individuals provided 1,610,562 RT-PCR results from nose and throat swabs in the COVID-19 Infection Survey (median [IQR] 3 [2 to 4]), of which 12,525 (0.8%) were the first positive in an infection episode and 1,598,037 (99.2%) were negative. Of 12,525 PCR-positives, 10,636 (85%) occurred in those ≥21 days before vaccination with no prior PCR/antibody-positive, 613 (5%) in those 1 to 21 days before vaccination with no prior PCR/antibody-positive, 238 (2%) in those first vaccinated 0 to 7 days ago, 421 (3%) in those first vaccinated 8 to 20 days ago, 417 (3%) in those vaccinated ≥21 days ago having received only one dose, 72 (1%) in those having received 2 vaccine doses, and 83 (1%) in those not vaccinated but previously PCR/antibody-positive.
Very few new infection episodes occurred in vaccinated individuals with evidence of previous
infection (i.e. prior PCR or antibody test positive) before vaccination (seven in those vaccinated 0 to
7 days ago, seven in those vaccinated 8 to 20 days ago, 11 in those ≥21 days after 1st dose with no
second dose, and six in those post second dose [Supplementary Table 3]) so these were classified
based on vaccination history alone. Of the 19,756 individuals who received a second vaccine dose,
3,437 (17%) had this 21 days after first vaccination, while the remainder received a second dose
median 59 days (IQR 36 to 71) later.
Ct values (inversely related to viral load) of new infections increased with increasing time from first
vaccination and number of doses (Figure 1; Supplementary Table 4). The highest Ct values were in
those who had received two vaccine doses, with a similar distribution to those not vaccinated but
previously PCR/antibody-positive. Ct values were lowest in those not vaccinated and not previously
PCR/antibody-positive. The percentage of PCR-positive cases self-reporting symptoms was highest in
those not vaccinated and not previously PCR/antibody-positive, and lowest in those with two
vaccine doses and those not vaccinated but previously PCR-/antibody-positive (Figure 2). Wellrecognised
COVID-19 symptoms (cough, fever, loss of taste/smell) were most commonly reported in
unvaccinated individuals and not previously PCR/antibody-positive, while other self-reported
symptoms occurred similarly across all vaccine exposure groups.
According to Google Maps, Sweden is currently at 49.6 cases per 100k.
Norway is at 11.3, Denmark is at 12.3, Finland is at 3.7. Baltics are all at least 27.
Next highest in Western Europe are Netherlands at 43.5, France at 32.2.
For comparison, India is at 27.7.
How does Tegnell keep his job?
Swedish people might not like lockdowns and are willing to accept more infected (but not dead) to keep as much as possible of normal life?
I don't think they succeeded in the keeping deaths down part either.
Are there no infected Swedes suffering from "long covid?"